ETHRIS
ETHRIS develops mRNA therapeutics with a focus on respiratory diseases and vaccines. ETHRIS possesses an enabling LNP delivery and mRNA modification platform for transcript Therapies. SNIM®RNAis a first-in-class biopharmaceutical which provide a compelling alternative for recombinant protein or gene therapies. SNIM®RNAs encode therapeutic proteins to be produced in the patient‘s body and overcome short duration effects of recombinant proteins. SNIM®RNA Transcript Therapy is a new option for a broad variety of diseases, either acquired or genetically predetermined, lifestyle- or age-related, rare or frequent.
ETHRIS
Industry:
Bioinformatics Biopharma Biotechnology Genetics Pharmaceutical
Founded:
2009-01-01
Address:
Planegg, Bayern, Germany
Country:
Germany
Website Url:
http://www.ethris.com
Total Employee:
101+
Status:
Active
Contact:
+4908989557880
Email Addresses:
[email protected]
Total Funding:
74.42 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Euro Microsoft Exchange Online Office 365 Mail IPv6
Similar Organizations
Bicycle Therapeutics
Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Current Employees Featured
Founder
Investors List
Laureus Capital
Laureus Capital investment in Series B - ETHRIS
Bavarian Ministry of Economics / Bayerisches Wirtschaftsministerium
Bavarian Ministry of Economics / Bayerisches Wirtschaftsministerium investment in Grant - ETHRIS
AstraZeneca
AstraZeneca investment in Corporate Round - ETHRIS
OrbiMed
OrbiMed investment in Series A - ETHRIS
HS LifeSciences
HS LifeSciences investment in Series A - ETHRIS
Official Site Inspections
http://www.ethris.com Semrush global rank: 7.11 M Semrush visits lastest month: 588
- Host name: vwp4608.webpack.hosteurope.de
- IP address: 83.169.26.88
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
More informations about "ETHRIS"
Home | ETHRIS
Delivering the Future of RNA Medicine Today. . Ethris has created a new path from genes to therapeutic proteins using its proprietary, non-immunogenic messenger RNA (SNIM mRNA) …See details»
ETHRIS - Crunchbase Company Profile & Funding
ETHRIS develops mRNA therapeutics with a focus on respiratory diseases and vaccines. ETHRIS possesses an enabling LNP delivery and mRNA modification platform for transcript Therapies. …See details»
Ethris GmbH | EuroQuity
About your organization / profile Ethris GmbH is a privately held clinical stage company focused on development of disruptive mRNA therapeutics for severe respiratory diseases, including …See details»
Ethris Company Profile - Office Locations, Competitors, Revenue
Ethris is a biopharmaceutical company focused on developing therapies for pulmonary diseases such as primary ciliary dyskinesia. It provides the Stabilized Non-Immunogenic mRNA (SNIM …See details»
ETHRIS GmbH - Drug pipelines, Patents, Clinical trials - Synapse
Ethris teamed up with Neurimmune back in 2020 to develop mRNA-based, neutralising antibodies for a Covid-19 therapeutic formulated for inhalation. ... The statistics for drugs in the Pipeline is …See details»
Ethris - VentureRadar
Ethris is a technical innovator in the emerging field of messenger RNA therapeutics. We are using our proprietary technologies to develop a new approach for the treatment of pulmonary …See details»
About - ETHRIS
About Ethris. Based in Planegg just outside Munich, Germany, Ethris was founded by Dr. Carsten Rudolph and Prof. Christian Plank to establish messenger RNA (mRNA) as a new drug modality. We are a team of dedicated scientists …See details»
ETHRIS COMPANY PRESENTATION - Swiss Biotech Day
Ethris manufacturing process offers multiple advantages compared to industry standard TFF Solvent free Modular setup Closed system Dephos-phorylation Industry standard Downstream …See details»
ethris - The Org
Ethris is a technical innovator in the emerging field of messenger RNA therapeutics. Industries. BiotechnologySee details»
Ethris Joins Alliance for mRNA Medicines as a Founding
Nov 1, 2023 Ethris has paved a new path from genes to therapeutic proteins, using its proprietary RNA and lipidoid nanoparticle technology platform to discover, design and develop …See details»
Ethris Company Overview, Contact Details & Competitors | LeadIQ
Jun 18, 2024 Ethris. Biotechnology Research Planegg, Germany 51-200 Employees. Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA …See details»
Ethris - BIO International Convention | BIO
Jun 8, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Ethris is …See details»
News - ETHRIS
Jan 30, 2025 Munich, Germany, May 6, 2025 – Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced that it …See details»
Ethris – germantech.org – Network
Ethris is interested in collaborations for licensing of its technology platform, co-development of new mRNA vaccines and therapeutics, and licensing partners for future commercialization of …See details»
Ethris Company Information - Funding, Investors, and More
The company Ethris has raised a total of $11m in funding over 1 rounds. Key Insights: Ethris Grant Funding Round, May 2025: $11m; 2025. Ethris Grant Funding Round, May 2025 $11m. …See details»
ETHRIS - Funding, Financials, Valuation & Investors - Crunchbase
ETHRIS is a technical innovator in the emerging field of mRNA therapeutics and LNP delivery. New. Resources. ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
Careers - ETHRIS
Careers. At Ethris, we are working at the forefront of medical innovation and technology. To us, this is a once-in-a-lifetime chance, working on rethinking human therapeutics. We strive …See details»
Home | ETHRIS
Delivering the Future of RNA Medicine Today. . Ethris has created a new path from genes to therapeutic proteins using its proprietary, clinically validated, non-immunogenic messenger …See details»
Pipeline - ETHRIS
Pipeline. Ethris’ wholly owned pipeline comprises first- or best-in-class mRNA-based product candidates for treatment of asthma and rare pulmonary diseases. The versatility of our …See details»
ETHRIS - Contacts, Employees, Board Members, Advisors & Alumni …
ETHRIS is a technical innovator in the emerging field of mRNA therapeutics and LNP delivery. New. Resources. Advanced Search. Start Free Trial ... Experience the new Crunchbase, …See details»